We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Test Predicts Diabetes Mellitus Type 1 Risk

By LabMedica International staff writers
Posted on 04 Jul 2013
Type 1 diabetes usually has a preclinical phase identified by circulating islet autoantibodies, but the rate of progression to diabetes after seroconversion to islet autoantibodies is equivocal.

Diabetes mellitus type 1 can occur at any age and it starts with the immune system destroying insulin-producing beta cells, which eventually stops the production of insulin and without insulin the body cannot control blood sugar or glucose. More...


Scientists based at the Helmholtz Zentrum (Munich, Germany) gathered data from three different studies, which included a total of 13,377 children. The study involved analyzing blood samples taken from children to identify any preclinical clues that indicate any increased risk of type 1 diabetes. Two diabetes-related autoantibodies were found to be the strongest indicators of diabetes risk.

The children’s genetic risk for type 1 diabetes was estimated by measuring the development of insulin autoantibodies, glutamic acid decarboxylase 65 (GAD65) autoantibodies, and insulinoma antigen 2 (IA2) autoantibodies. At the 10-year follow-up, an overwhelming 70% of the children with multiple islet autoantibodies developed type 1 diabetes, compared to 15% among those with just one autoantibody.

At follow-up, 8% of the children had one or more of the autoantibodies, indicators for the destruction of insulin, 585 children had at least two autoantibodies and 474 were found to have just one. Nearly half of the children with two or more autoantibodies went on to develop diabetes within five years, and four out of every five of them became diabetic within fifteen years. Only 14.5% of children with just one autoantibody developed type 1 diabetes after 10 years.

The authors concluded that the detection of multiple islet autoantibodies in children who are genetically at risk marks a preclinical stage of type 1 diabetes. Thus, the development of multiple islet autoantibodies in children predicts type 1 diabetes. Future prevention studies should focus on this high-risk population.

"Jay S. Skyler, MD, and Jay M. Sosenko, MD, both from the Leonard M. Miller School of Medicine (Miami, FL, USA) wrote in an accompanying editorial: "If you have two or more autoantibodies, it's nearly inevitable that you will develop the disease. Most people, even physicians, don't appreciate this risk." The study was published on June 19, 2013, in the Journal of the American Medical Association.

Related Links:
Helmholtz Zentrum
Leonard M. Miller School of Medicine



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Using deep sequencing of cell-free fetal DNA from maternal blood and advanced computational analysis, the method reconstructs fetal variants across the exome (Image credit: Adobe Stock)

Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening

Prenatal genetic evaluation guides obstetric care, but standard diagnostics often require invasive procedures that carry risks, stress, and access barriers. Noninvasive prenatal testing (NIPT) has expanded... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.